AMPK modulates Hippo pathway activity to regulate energy homeostasis

Wang, Wenqi, Xiao, Zhen-Dong, Li, Xu, Aziz, Kathryn E., Gan, Boyi, Johnson, Randy L., Chen, Junjie·2015·Nature Cell Biology

Cited by (550)

Items 101–200 of 550

  1. The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
    Mohammad Reza Zinatizadeh, Seyed Rouhollah Miri, Peyman Kheirandish Zarandi, Ghanbar Mahmoodi Chalbatani, Catarina Rapôso, Hamid Reza Mirzaei, Mohammad Esmaeil Akbari, Habibollah Mahmoodzadeh · 2019 · Genes & Diseases
  2. Hippo and TGF-β interplay in the lung field
    Akira Saito, Takeshi Nagase · 2015 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  3. Dissecting the role of AMP-activated protein kinase in human diseases
    Jin Li, Liping Zhong, Fengzhong Wang, Haibo Zhu · 2017 · Acta Pharmaceutica Sinica B
  4. Evidence of cancer‐promoting roles for AMPK and related kinases
    Tiziana Monteverde, Nathiya Muthalagu, Jennifer Port, Daniel J. Murphy · 2015 · FEBS Journal
  5. Signaling pathways and intervention for therapy of type 2 diabetes mellitus
    Rong Yue Cao, Huimin Tian, Yu Zhang, Geng Liu, Haixia Xu, Guocheng Rao, Yan Tian, Xianghui Fu · 2023 · MedComm
  6. TNFα-YAP/p65-HK2 axis mediates breast cancer cell migration
    Yin Gao, Y Yang, F Yuan, Jinhua Huang, Wenli Xu, B Mao, Zengqiang Yuan, Wenzhi Bi · 2017 · Oncogenesis
  7. p53 shades of Hippo
    Noa Furth, Yael Aylon, Moshe Oren · 2017 · Cell Death and Differentiation
  8. The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization
    Lei Li, Tongzheng Liu, Yunhui Li, Chenming Wu, Kuntian Luo, Yujiao Yin, Yuping Chen, Somaira Nowsheen, Jinhuan Wu, Zhenkun Lou et al. · 2018 · Oncogene
  9. AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness
    Xinbo Wang, Jiali Jin, Fangning Wan, Linlin Zhao, Hongshang Chu, Cong Chen, Guanghong Liao, Jian Liu, Yue Yu, Hongqi Teng et al. · 2018 · Developmental Cell
  10. The Hippo signaling pathway provides novel anti-cancer drug targets
    June Sung Bae, Sun Mi Kim, Ho Lee · 2016 · Oncotarget
  11. TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells
    Dana Elster, Marie Tollot, Karin Schlegelmilch, Alessandro Ori‬‬, Andreas Rosenwald, Erik A. Sahai, Björn von Eyß · 2018 · Nature Communications
  12. GLUT and HK: Two primary and essential key players in tumor glycolysis
    Dhiraj Yadav, Anubha Yadav, Sujata Bhattacharya, Akansha Dagar, Vinit Kumar, Reshma Rani · 2024 · Seminars in Cancer Biology
  13. KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops
    Guido Eibl, Enrique Rozengurt · 2017 · Seminars in Cancer Biology
  14. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy
    Wen Chun Juan, Wanjin Hong · 2016 · Genes
  15. Regulation of localization and function of the transcriptional co-activator YAP by angiomotin
    Susana Moleirinho, Sany Hoxha, Vinay Mandati, Graziella Curtale, Scott A. Troutman, Ursula Ehmer, Joseph L. Kissil · 2017 · eLife
  16. The Hippo Pathway in Prostate Cancer
    Omar Salem, Carsten Gram Hansen · 2019 · Cells
  17. Vinculin promotes nuclear localization of TAZ to inhibit ECM stiffness-dependent differentiation into adipocytes
    Mito Kuroda, Hiroki Wada, Yasuhisa Kimura, Kazumitsu Ueda, Noriyuki Kioka · 2017 · Journal of Cell Science
  18. A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas
    Shigekazu Murakami, Ivan Nemazanyy, Shannon M. White, Hengye Chen, Chan D.K. Nguyen, Garrett T. Graham, Dieter Saur, Mario Pende, Chunling Yi · 2019 · Developmental Cell
  19. Atheroprotective laminar flow inhibits Hippo pathway effector YAP in endothelial cells
    Suowen Xu, Marina Koroleva, Meimei Yin, Zheng Gen Jin · 2016 · Translational research
  20. Mechanotransduction in the pathogenesis of non-alcoholic fatty liver disease
    Emilie K. Mitten, György Baffy · 2022 · Journal of Hepatology
  21. Notch and Hippo signaling converge on Strawberry Notch 1 (Sbno1) to synergistically activate Cdx2 during specification of the trophectoderm
    Yusuke Watanabe, Kota Y. Miyasaka, Atsushi Kubo, Yasuyuki S. Kida, Osamu Nakagawa, Yoshikazu Hirate, Hiroshi Sasaki, Toshihiko Ogura · 2017 · Scientific Reports
  22. YAP promotes ocular neovascularization by modifying PFKFB3-driven endothelial glycolysis
    Yifan Feng, Rong Zou, Xi Zhang, Minqian Shen, Xiuping Chen, Jing Wang, Weiran Niu, Yuanzhi Yuan, Fei Yuan · 2021 · Angiogenesis
  23. Regulation of the Hippo pathway in cancer biology
    Sungho Moon, So Yeon Park, Hyun Woo Park · 2018 · Cellular and Molecular Life Sciences
  24. Non-canonical functions of enzymes facilitate cross-talk between cell metabolic and regulatory pathways
    Marteinn Thor Snaebjornsson, Almut Schulze · 2018 · Experimental & Molecular Medicine
  25. YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine
    Zhengdong Jiang, Xin Chen, Ke Chen, Liankang Sun, Luping Gao, Cancan Zhou, Lei Meng, Wanxing Duan, Zheng Wang, Qingyong Ma et al. · 2016 · Nutrients
  26. The history and regulatory mechanism of the Hippo pathway
    Wantae Kim, Eek‐hoon Jho · 2018 · BMB Reports
  27. Mechanical cue‐induced YAP instructs Skp2‐dependent cell cycle exit and oncogenic signaling
    Wonyul Jang, Tackhoon Kim, Ja Seung Koo, Sang Kyum Kim, Dae‐Sik Lim · 2017 · The EMBO Journal
  28. Upstairs, downstairs: spatial regulation of Hippo signalling
    Alexander D. Fulford, Nicolas Tapon, Paulo S. Ribeiro · 2017 · Current Opinion in Cell Biology
  29. Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner
    Yoonmi Lee, Nam Hee Kim, Eunae Sandra Cho, Ji Hye Yang, Yong Hoon Cha, Hee Eun Kang, Jun Seop Yun, Sue Bean Cho, Seon-Hyeong Lee, Petra Paclíková et al. · 2018 · Nature Communications
  30. EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance
    Changhao Huang, Weijie Yuan, Chen Lai, Shangwei Zhong, Yang Chen, Ran Wang, Linfeng Mao, Zihua Chen, Zhikang Chen · 2019 · International Journal of Cancer
  31. Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells
    Xiao-Yang Dai, Linhan Zhuang, Dandan Wang, Tianyi Zhou, Lin-Lin Chang, Renhua Gai, Difeng Zhu, Bo Yang, Hong Zhu, Qiaojun He · 2016 · Oncotarget
  32. A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas
    Michael D. Deel, Jing Li, Lisa E.S. Crose, Corinne Mary Linardic · 2015 · Frontiers in Oncology
  33. A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer
    Ayesha Khan, Daniel E. Frigo · 2017 · Nature Reviews Urology
  34. The Ambivalent Function of YAP in Apoptosis and Cancer
    Xianbin Zhang, Ahmed Abdelrahman, Brigitte Vollmar, Dietmar Zechner · 2018 · International Journal of Molecular Sciences
  35. Attacking the supply wagons to starve cancer cells to death
    Elizabeth M. Selwan, Brendan T. Finicle, Seong Min Kim, Aimee L. Edinger · 2016 · FEBS Letters
  36. Targeting mutant p53 in cancer: a long road to precision therapy
    Fiamma Mantovani, Dawid Walerych, Giannino Del Sal · 2016 · FEBS Journal
  37. CoenzymeQ10-Induced Activation of AMPK-YAP-OPA1 Pathway Alleviates Atherosclerosis by Improving Mitochondrial Function, Inhibiting Oxidative Stress and Promoting Energy Metabolism
    Tianqi Xie, Changyuan Wang, Yue Jin, Qiang Meng, Qi Liu, Jingjing Wu, Huijun Sun · 2020 · Frontiers in Pharmacology
  38. DNA-binding mechanism of the Hippo pathway transcription factor TEAD4
    Zhubing Shi, F He, Mei Chen, Lei Hua, Wenshuai Wang, Shi Jiao, Zhaocai Zhou · 2017 · Oncogene
  39. MST4 kinase suppresses gastric tumorigenesis by limiting YAP activation via a non-canonical pathway
    Liwei An, Pingping Nie, Min Chen, Yang Tang, Hui Zhang, Jingmin Guan, Zhifa Cao, Chun Hou, Wenjia Wang, Yun Zhao et al. · 2020 · The Journal of Experimental Medicine
  40. Dysregulation of the Hippo pathway signaling in aging and cancer
    Yiu To Yeung, Angélica Guerrero‐Castilla, Mercedes Cano, Mario F. Muñoz, Antonio Ayala, Sandro Argüelles · 2019 · Pharmacological Research
  41. Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer
    Yasmin Dekker, Sylvia E. Le Dévédec, Erik H.J. Danen, Qiuyu Liu · 2022 · Genes
  42. PHLDA2-mediated phosphatidic acid peroxidation triggers a distinct ferroptotic response during tumor suppression
    Xin Ping Yang, Zhe Wang, Светлана Николаевна Самович, Alexandr A. Kapralov, Andrew A. Amoscato, Vladimir A. Tyurin, Haider Hussain Dar, Zhiming Li, Shoufu Duan, Ning Kon et al. · 2024 · Cell Metabolism
  43. Emerging Principles in the Transcriptional Control by YAP and TAZ
    Alejandro Lopez-Hernandez, Silvia Sberna, Stefano Campaner · 2021 · Cancers
  44. YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis
    Chunli Lin, Xiaofeng Xu · 2017 · Biomedicine & Pharmacotherapy
  45. Metabolic and Mechanical Cues Regulating Pluripotent Stem Cell Fate
    Tânia Perestrelo, Marcelo Correia, João Ramalho‐Santos, Denis Wirtz · 2018 · Trends in Cell Biology
  46. Transcriptional co-activators YAP/TAZ: Potential therapeutic targets for metastatic breast cancer
    Wenxia Zhao, Mengyan Wang, Meilian Cai, Cong-Hui Zhang, Yuhan Qiu, Xiaowei Wang, Tianshu Zhang, Huimin Zhou, Junxia Wang, Wuli Zhao et al. · 2020 · Biomedicine & Pharmacotherapy
  47. New Insights into YAP/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in Cancer
    Yang Zhao, Marisela Sheldon, Yutong Sun, Li Ma · 2023 · Cancers
  48. Aurora A kinase activates YAP signaling in triple-negative breast cancer
    S.H. Chang, Hirohito Yamaguchi, W Xia, S-O Lim, Yekaterina B. Khotskaya, Yun Wu, W-C Chang, Qinqin Liu, Mien‐Chie Hung · 2016 · Oncogene
  49. Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
    Yoshitaka Sekido · 2018 · Cancers
  50. Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway
    Jie Liu, Juan Li, He Chen, Ruiqi Wang, Pingping Li, Yi Miao, Peijun Liu · 2020 · Journal of Cellular and Molecular Medicine
  51. Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases
    Yue Yu, Xingli Su, Qiaohong Qin, Ying Hou, Xin Zhang, Hongmei Zhang, Min Jia, Yulong Chen · 2020 · Pharmacological Research
  52. Pulmonary Arterial Stiffness: An Early and Pervasive Driver of Pulmonary Arterial Hypertension
    Wei Sun, Stephen Y. Chan · 2018 · Frontiers in Medicine
  53. O -GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity
    Eunah Kim, Jeong Gu Kang, Min Jueng Kang, Jae Hyung Park, Yeon Jung Kim, Tae Hyun Kweon, Han‐Woong Lee, Eek‐hoon Jho, Yong‐ho Lee, Seung-Il Kim et al. · 2020 · Proceedings of the National Academy of Sciences
  54. Hippo Signaling Pathway Has a Critical Role in Zika Virus Replication and in the Pathogenesis of Neuroinflammation
    Gustavo Garcia, Sayan Paul, Sara Beshara, V. Krishnan Ramanujan, Arunachalam Ramaiah, Karin Nielsen‐Saines, Melody M. H. Li, Samuel William French, Kouki Morizono, Ashok Kumar et al. · 2020 · American Journal Of Pathology
  55. Relationship between apical junction proteins, gene expression and cancer
    Lorenza González‐Mariscal, Jael Miranda, Helios Gallego-Gutiérrez, Misael Cano-Cortina, Elida Amaya · 2020 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  56. YAP regulates an SGK1/mTORC1/SREBP-dependent lipogenic program to support proliferation and tissue growth
    Srimayee Vaidyanathan, Talhah M. Salmi, Rasan M Sathiqu, Malcolm John McConville, Andrew Graham Cox, Kristin Brown · 2022 · Developmental Cell
  57. LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism
    Xinyu He, Fan Xiao, Lei Qu, Xiang Wang, Li Jiang, Lingjie Sang, Chengyu Shi, Siyi Lin, Jiecheng Yang, Zuozhen Yang et al. · 2023 · Nature Communications
  58. The AMPK-Sirtuin 1-YAP axis is regulated by fluid flow intensity and controls autophagy flux in kidney epithelial cells
    Aurore Claude‐Taupin, Pierre Isnard, Alessia Bagattin, Nicolas Kuperwasser, Federica Roccio, Biagina Ruscica, Nicolas Goudin, Meriem Garfa‐Traoré, Alice Regnier, Lisa Turinsky et al. · 2023 · Nature Communications
  59. Differential control of Yorkie activity by LKB1/AMPK and the Hippo/Warts cascade in the central nervous system
    Ieva Gailite, Birgit L. Aerne, Nicolas Tapon · 2015 · Proceedings of the National Academy of Sciences
  60. Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers
    Maria A. Ferraiuolo, Lorena Verduci, Giovanni Blandino, Sabrina Strano · 2017 · International Journal of Molecular Sciences
  61. Structural and Functional Overview of TEAD4 in Cancer Biology
    Mu Chen, Bingsong Huang, Lei Zhu, Kui Chen, Min Liu, Chunlong Zhong · 2020 · OncoTargets and Therapy
  62. Role of Angiomotin‐like 2 mono‐ubiquitination on YAP inhibition
    Miju Kim, Minchul Kim, Seong‐Jun Park, Cheolju Lee, Dae‐Sik Lim · 2015 · EMBO Reports
  63. Identification of the kinase STK25 as an upstream activator of LATS signaling
    Sanghee Lim, Nicole M. Hermance, Tenny Mudianto, Hatim M. Mustaly, Ian Paolo Morelos Mauricio, Marc A. Vittoria, Ryan J. Quinton, Brian W. Howell, Hauke Cornils, Amity L. Manning et al. · 2019 · Nature Communications
  64. Phytochemicals regulate cancer metabolism through modulation of the AMPK/PGC-1α signaling pathway
    Sajad Fakhri, Seyed Zachariah Moradi, Seyed Yahya Moradi, Sarina Piri, Behrang Shiri Varnamkhasti, Sana Piri, Mohammad Reza Khirehgesh, Ankur Bishayee, Nicolette Casarcia, Anupam Bishayee · 2024 · BMC Cancer
  65. Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis
    Xingcheng Chen, Seth Stauffer, Yuanhong Chen, Jixin Dong · 2016 · Journal of Biological Chemistry
  66. Regulation of TAZ in cancer
    Xin Zhou, Qun‐Ying Lei · 2016 · Protein & Cell
  67. The short isoform of PRLR suppresses the pentose phosphate pathway and nucleotide synthesis through the NEK9-Hippo axis in pancreatic cancer
    Hui Nie, Pei-Qi Huang, Shu-Heng Jiang, Qin Yang, Li-Peng Hu, Xiaomei Yang, Jun Li, Yahui Wang, Qing Li, Yifan Zhang et al. · 2021 · Theranostics
  68. Cold-induced protein RBM3 orchestrates neurogenesis via modulating Yap mRNA stability in cold stress
    Wenlong Xia, Libo Su, Jianwei Jiao · 2018 · The Journal of Cell Biology
  69. LncRNAs-directed PTEN enzymatic switch governs epithelial–mesenchymal transition
    Qingsong Hu, Chunlai Li, Shouyu Wang, Yajuan Li, Bo Wen, Yanyan Zhang, Ke Liang, Jun Yao, Youqiong Ye, Heidi Hao-yun Hsiao et al. · 2019 · Cell Research
  70. Dysfunctional Mechanotransduction through the YAP/TAZ/Hippo Pathway as a Feature of Chronic Disease
    Mathias Cobbaut, Simge Karagil, Lucrezia Bruno, María del Carmen Díaz de la Loza, Francesca E. Mackenzie, Michael Stolinski, Ahmed Elbediwy · 2020 · Cells
  71. Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical View
    Yong Suk Cho, Jin Jiang · 2021 · Frontiers in Cell and Developmental Biology
  72. Regulation of Tissue Growth by the Mammalian Hippo Signaling Pathway
    Kevin I. Watt, Kieran F. Harvey, Paul Gregorevic · 2017 · Frontiers in Physiology
  73. Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187
    Zhonghao Wang, Qiong Kong, Peng Su, Miao Duan, Min Xue, Xin Li, Jianing Tang, Zhitao Gao, Beibei Wang, Zhongbo Li et al. · 2020 · Oncogenesis
  74. YAP in pancreatic cancer: oncogenic role and therapeutic strategy
    Wenhao Mao, Jia Mai, Hui Peng, Junhu Wan, Ting Sun · 2020 · Theranostics
  75. TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression
    Jun-Ha Hwang, A Rum Kim, Kyung Min Kim, Jung Il Park, Ho Taek Oh, Sung Ah Moon, Mi Ran Byun, Hana Jeong, Hyo Kyung Kim, Michael B. Yaffe et al. · 2019 · Nature Communications
  76. Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast Cancer
    Sara El‐Sahli, Lisheng Wang · 2020 · International Journal of Molecular Sciences
  77. The hippo pathway: A master regulator of liver metabolism, regeneration, and disease
    Nguyen‐Lefebvre, Anh Thu, Selzner, Nazia, Wrana, Jeffrey L., Bhat, Mamatha · 2021 · The FASEB Journal
  78. Metformin: review of epidemiology and mechanisms of action in pancreatic cancer
    Guido Eibl, Enrique Rozengurt · 2021 · Cancer and Metastasis Reviews
  79. Targeting the Hippo pathway in heart repair
    Fansen Meng, Bing Xie, James F. Martin · 2021 · Cardiovascular Research
  80. O-GlcNAcylation regulation of cellular signaling in cancer
    Lorela Ciraku, Emily M. Esquea, Mauricio J. Reginato · 2021 · Cellular Signalling
  81. Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington’s Disease and Other Neurodegenerative Disorders
    Pasquale Sileo, C. Simonin, Patricia Melnyk, Marie‐Christine Chartier‐Harlin, Philippe Cotelle · 2022 · Cells
  82. Advances in glucose metabolism research in colorectal cancer
    Sitian Fang, Xiao Fang · 2016 · Biomedical Reports
  83. Hippo‐Yap/Taz signaling: Complex network interactions and impact in epithelial cell behavior
    Benjamin J. van Soldt, Wellington Veras Cardoso · 2019 · Wiley Interdisciplinary Reviews Developmental Biology
  84. The Hippo signal transduction network for exercise physiologists
    Gabriel, Brendan M., Hamilton, D. Lee, Tremblay, Annie M., Wackerhage, Henning · 2016 · Journal of Applied Physiology
  85. Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential
    Liemei Lv, Xiangxiang Zhou · 2023 · MedComm
  86. Hippo Signaling at the Hallmarks of Cancer and Drug Resistance
    Ramesh Kumar, Wanjin Hong · 2024 · Cells
  87. Targeting the Hippo signalling pathway for cancer treatment
    Keisuke Nakatani, Tomohiko Maehama, Miki Nishio, Hiroki Goto, Wakako Kato, Hirofumi Omori, Yosuke Miyachi, Hideru Togashi, Yohei Shimono, Akira Suzuki · 2016 · The Journal of Biochemistry
  88. Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow
    Dandan Liu, Hang Lv, Qi Liu, Yanli Sun, Shenglong Hou, Lu Zhang, Mengyue Yang, Baihe Han, Gang wang, Xuedong Wang et al. · 2019 · Journal of Translational Medicine
  89. Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck
    Karla Santos-de-Frutos, Carmen Segrelles, Corina Lorz · 2019 · Journal of Clinical Medicine
  90. Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease
    K. Watt, D. Henstridge, M. Ziemann, C. Sim, M. Montgomery, D. Samocha-Bonet, B. Parker, G. Dodd, S. Bond, T. M. Salmi et al. · 2021 · Nature Communications
  91. Transcriptional Repression of Ferritin Light Chain Increases Ferroptosis Sensitivity in Lung Adenocarcinoma
    Yikun Wang, Shiyu Qiu, Hong Wang, Jiangtao Cui, Xiaoting Tian, Yayou Miao, Congcong Zhang, Leiqun Cao, Lifang Ma, Xin Xu et al. · 2021 · Frontiers in Cell and Developmental Biology
  92. Metabolic Remodeling in Glioma Immune Microenvironment: Intercellular Interactions Distinct From Peripheral Tumors
    Runze Qiu, Yue Zhong, Qingquan Li, Yingbin Li, Hongwei Fan · 2021 · Frontiers in Cell and Developmental Biology
  93. AMPK at the interface of nutrient sensing, metabolic flux and energy homeostasis
    Tyler K.T. Smith, Logan K. Townsend, William J. Smiles, Jonathan S. Oakhill, Morgan D. Fullerton, Gregory R Steinberg · 2026 · Nature Metabolism
  94. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2
    Gun-Soo Park, Hyangyee Oh, Minchul Kim, Tackhoon Kim, Randy L. Johnson, Kenneth D. Irvine, Dae‐Sik Lim · 2016 · Oncotarget
  95. Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness
    Nesrine Rachedi, Ying Tang, Yi-Yin Tai, Jingsi Zhao, Caroline Chauvet, Julien Grynblat, Kouamé Kan Firmin Akoumia, Leonard E. Estephan, Stéphanie Torrino, Chaima Sbai et al. · 2024 · Cell Metabolism
  96. The Hippo pathway: Organ size control and beyond
    Pengfei Guo, Sicheng Wan, Kun‐Liang Guan · 2024 · Pharmacological Reviews
  97. Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies
    Enrique Rozengurt, Guido Eibl · 2026 · Signal Transduction and Targeted Therapy
  98. Loss of tricellular tight junction protein LSR promotes cell invasion and migration via upregulation of TEAD1/AREG in human endometrial cancer
    Hiroshi Shimada, Shyuetsu Abe, Takayuki Kohno, Seiro Satohisa, Takumi Konno, Syunta Takahashi, Tsubasa Hatakeyama, Chihiro Arimoto, Takuya Kakuki, Yakuto Kaneko et al. · 2017 · Scientific Reports
  99. 2-Hydroxylation of Fatty Acids Represses Colorectal Tumorigenesis and Metastasis via the YAP Transcriptional Axis
    Liang Sun, Xiaoqin Yang, Xiaoheng Huang, Yizhou Yao, Xiangyu Wei, Shugao Yang, Diyuan Zhou, Wei Zhang, Zhimin Long, Xiaoyan Xu et al. · 2020 · Cancer Research
  100. The regulatory networks of the Hippo signaling pathway in cancer development
    Maonan Wang, Manli Dai, Dan Wang, Wei Xiong, Zhaoyang Zeng, Can Jie Guo · 2021 · Journal of Cancer